Bayer Pharma continues to boost its presence in the Asia-Pacific
2015 regional revenue rises 7% to 4b euros; clinical trials triple in 9 years
Singapore
The number of clinical trials conducted by Bayer Pharmaceuticals in Asia Pacific has more than tripled since 2007 - from 21 to 68 - as the healthcare group strengthens its focus on the region.
Here in Singapore, the number of trials has expanded nearly fourfold to 22 from six in the same time frame.
The growing number of trials in the region is testament both to the …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
P&G raises annual core profit forecast on resilient demand, price hikes
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO